Cargando…
Risk stratification in therapy-related myelodysplastic syndromes
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655180/ https://www.ncbi.nlm.nih.gov/pubmed/29113285 http://dx.doi.org/10.18632/oncotarget.21178 |
| _version_ | 1783273480329887744 |
|---|---|
| author | Zeidan, Amer M. |
| author_facet | Zeidan, Amer M. |
| author_sort | Zeidan, Amer M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5655180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56551802017-11-06 Risk stratification in therapy-related myelodysplastic syndromes Zeidan, Amer M. Oncotarget Editorial Impact Journals LLC 2017-09-24 /pmc/articles/PMC5655180/ /pubmed/29113285 http://dx.doi.org/10.18632/oncotarget.21178 Text en Copyright: © 2017 Zeidan http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Editorial Zeidan, Amer M. Risk stratification in therapy-related myelodysplastic syndromes |
| title | Risk stratification in therapy-related myelodysplastic syndromes |
| title_full | Risk stratification in therapy-related myelodysplastic syndromes |
| title_fullStr | Risk stratification in therapy-related myelodysplastic syndromes |
| title_full_unstemmed | Risk stratification in therapy-related myelodysplastic syndromes |
| title_short | Risk stratification in therapy-related myelodysplastic syndromes |
| title_sort | risk stratification in therapy-related myelodysplastic syndromes |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655180/ https://www.ncbi.nlm.nih.gov/pubmed/29113285 http://dx.doi.org/10.18632/oncotarget.21178 |
| work_keys_str_mv | AT zeidanamerm riskstratificationintherapyrelatedmyelodysplasticsyndromes |